The diagnostic application of these tau isoforms in AD offers a promising alternative for overcoming the challenge of differential diagnosis in conditions such as frontotemporal dementia (FTD) and traumatic brain injury (TBI), where elevated tau levels alone are insufficient for disease discrimination. This evidence concerns the gene MAPT and Alzheimer disease.